Go Pro

Damora Therapeutics, Inc. Common Stock (DMRA) Short Interest Ratio & Short Volume

Damora Therapeutics, Inc. Common Stock logo
$22.59 -0.19 (-0.83%)
As of 09/18/2026 04:00 PM Eastern

Damora Therapeutics, Inc. Common Stock Short Interest Overview

As of August 31, 2026, Damora Therapeutics, Inc. Common Stock (DMRA) had a short interest of 4.13 million shares sold short, representing 6.72% of the public float. This marks a -12.84% decrease in short interest since the prior report. The short interest ratio (days to cover) is 13.3, meaning it would take 13.3 days of the average trading volume of 469,673 shares to cover all short positions.

Current Short Interest
4,131,367 shares
Previous Short Interest
4,739,939 shares
Change Vs. Previous Month
-12.84%
Dollar Volume Sold Short
$116.42 million
Short Interest Ratio
13.3 Days to Cover
Last Record Date
August 31, 2026
Outstanding Shares
61,740,000 shares
Short Percent of Float
6.72%
Today's Trading Volume
3,316,841 shares
Average Trading Volume
469,673 shares
Today's Volume Vs. Average
706%
Short Selling Damora Therapeutics, Inc. Common Stock?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Damora Therapeutics, Inc. Common Stock and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

DMRA Short Interest Over Time

DMRA Days to Cover Over Time

DMRA Percentage of Float Shorted Over Time

Damora Therapeutics, Inc. Common Stock Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/20264,131,367 shares $116.42 million -12.8%6.7%13.27 $28.18
8/14/20264,739,939 shares $147.13 million -3.1%7.7%13.57 $31.04
7/31/20264,893,454 shares $141.86 million +4.4%8.0%11.71 $28.99
7/15/20264,688,241 shares $145.10 million +31.4%7.6%8.08 $30.95
6/30/20263,567,900 shares $92.80 million +172.3%5.8%2.63 $26.01
6/15/20261,310,364 shares $26.30 million -6.6%2.1%3.37 $20.07
5/29/20261,402,988 shares $34.91 million +8.7%2.3%4.14 $24.88
5/15/20261,290,741 shares $31.75 million +8.4%2.1%3.09 $24.60
4/30/20261,191,070 shares $30.56 million +6.7%2.0%5.51 $25.66
4/15/20261,116,620 shares $29.71 million +35.0%1.8%4.72 $26.61
3/31/2026827,221 shares $21.43 million +93.4%1.3%2.46 $25.90
3/13/2026427,713 shares $12.19 million +31.6%0.8%1.94 $28.50
2/27/2026325,076 shares $9.62 million +17.4%22.7%1.13 $29.58
2/13/2026277,004 shares $8.07 million +86.6%19.4%0.6 $29.12
1/30/2026148,474 shares $3.90 million -12.3%10.4%4.56 $26.24
1/15/2026169,350 shares $4.06 million -1.8%11.8%6.28 $23.95
12/31/2025172,444 shares $3.97 million -4.8%12.1%2.31 $23.01
12/15/2025181,086 shares $5.72 million +8.1%12.7%1.15 $31.60
11/28/2025167,465 shares $2.90 million -50.4%14.1%0.8 $17.35
11/14/2025337,430 shares $9.05 million +920.8%28.5%0.05 $26.83
10/31/202533,054 shares $241.96 thousand -62.9%2.8%0.33 $7.32
10/15/202589,100 shares $1.04 million -32.1%7.1%0 $11.68
9/30/2025131,200 shares $488.06 thousand +57.7%11.3%0.1 $3.72
9/15/202583,200 shares $235.46 thousand +560.3%7.3%0.1 $2.83
8/31/202512,600 shares $40.02 thousand -34.4%1.1%0.1 $3.18
8/15/202519,200 shares $65.38 thousand -30.2%1.7%0.9 $3.41
7/31/202527,500 shares $90.61 thousand -30.6%2.4%0.6 $3.30
7/15/202539,600 shares $140.58 thousand +7.3%3.5%0.9 $3.55
6/30/202536,900 shares $125.83 thousand -18.0%3.2%0.8 $3.41
6/15/202545,000 shares $150.75 thousand -40.4%4.0%0.5 $3.35
5/31/202575,500 shares $234.81 thousand +36.3%6.6%0.3 $3.11
5/15/202555,400 shares $161.21 thousand -20.4%4.9%0.2 $2.91
4/30/202569,600 shares $194.88 thousand +20.8%6.1%0.3 $2.80
4/15/202557,600 shares $148.03 thousand -11.0%5.1%0.2 $2.57
3/31/202564,700 shares $200.57 thousand +133.6%5.7%0.3 $3.10
3/15/202527,700 shares $112.19 thousand +51.4%2.4%0.1 $4.05
2/28/202518,300 shares $80.15 thousand -10.3%1.6%1 $4.38
2/15/202520,400 shares $97.51 thousand +56.9%1.8%1 $4.78
1/31/202513,000 shares $65 thousand -27.4%1.1%0.7 $5.00
1/15/202517,900 shares $86.28 thousand +6.6%1.6%0.9 $4.82
Bank of America: 'Digital Dollar Inevitable' (Ad)

Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the digital dollar. They gave us the timeline… 2025 to 2030. We're in that window right now. Once the digital dollar launches, every transaction you make will be tracked. Your spending could be controlled. Your accounts could be frozen. Over 4,500 investors have already used this legal backdoor to hold assets CBDCs can't freeze and generate yields the Federal Reserve can't touch.tc pixel

Watch how to access the legal backdoor before it closes.
12/31/202416,800 shares $78.12 thousand -30.9%1.5%0.8 $4.65
12/15/202424,300 shares $123.44 thousand +20.3%2.1%0.9 $5.08
11/30/202420,200 shares $107.06 thousand +112.6%1.8%0.7 $5.30
11/15/20249,500 shares $60.42 thousand +97.9%0.8%0.2 $6.36
10/31/20244,800 shares $32.88 thousand -48.9%0.4%0.1 $6.85
10/15/20249,400 shares $63.26 thousand -36.1%0.9%0.3 $6.73
9/30/202414,700 shares $178.61 thousand +129.7%1.4%0.5 $12.15
9/15/20246,400 shares $82.75 thousand -62.1%0.6%0.3 $12.93
8/31/202416,900 shares $201.96 thousand +98.8%1.9%1 $11.95
8/15/20248,500 shares $4.68 thousand +3.7%0.0%0.1 $0.55
7/31/20248,200 shares $4.62 thousand +173.3%0.0%0.1 $0.56
7/15/20243,000 shares $1.77 thousand -90.3%0.0%0 $0.59
6/30/202430,800 shares $14.61 thousand +1,084.6%0.2%0.2 $0.47
6/15/20242,600 shares $1.38 thousand -72.0%0.0%0 $0.53
5/31/20249,300 shares $5.65 thousand -80.4%0.1%0.1 $0.61
5/15/202447,400 shares $30.14 thousand -44.4%0.2%0.3 $0.64
4/30/202485,300 shares $58.77 thousand +373.9%0.4%0.4 $0.69
4/15/202418,000 shares $12.37 thousand -42.9%0.1%0.1 $0.69
3/31/202431,500 shares $24.57 thousand +74.0%0.2%0.1 $0.78
3/15/202418,100 shares $14.80 thousand -66.9%0.1%0 $0.82
2/29/202454,600 shares $39.32 thousand +39.6%0.3%0.1 $0.72
2/15/202439,100 shares $26.60 thousand -40.5%0.2%0.1 $0.68
1/31/202465,700 shares $40.21 thousand -53.0%0.3%0.2 $0.61
1/15/2024139,800 shares $96.18 thousand -54.3%0.7%0.4 $0.69
12/31/2023306,000 shares $220.32 thousand +332.2%1.6%0.8 $0.72
12/15/202370,800 shares $43.05 thousand -61.4%0.4%0.1 $0.61
11/30/2023183,400 shares $115.54 thousand -26.1%1.0%0.4 $0.63
11/15/2023248,000 shares $152.05 thousand -46.5%1.3%0.5 $0.61
10/31/2023463,900 shares $245.91 thousand -32.6%2.4%0.7 $0.53
10/15/2023688,500 shares $425.15 thousand -53.8%3.5%0.9 $0.62
9/30/20231,490,000 shares $1.07 million +337.5%7.0%2 $0.72
9/15/2023340,600 shares $201.87 thousand +95.8%1.6%0.7 $0.59
8/31/2023174,000 shares $105.27 thousand -55.9%0.8%0.4 $0.61
8/15/2023394,500 shares $265.70 thousand +73.0%2.0%1 $0.67
7/31/2023228,100 shares $702.55 thousand +403.5%1.2%1.3 $3.08
7/15/202345,300 shares $108.72 thousand -4.0%0.3%0.4 $2.40
6/30/202347,200 shares $118.94 thousand +271.7%0.3%0.7 $2.52
6/15/202312,700 shares $27.94 thousand +4.1%0.1%0.2 $2.20
5/31/202312,200 shares $26.60 thousand +3.4%0.1%0.2 $2.18
5/15/202311,800 shares $25.25 thousand -3.3%0.1%0.2 $2.14
4/30/202312,200 shares $21.47 thousand -63.8%0.1%0.2 $1.76
4/15/202333,700 shares $64.03 thousand +163.3%0.2%0.7 $1.90
3/31/202312,800 shares $25.47 thousand -25.6%0.1%0.3 $1.99
3/15/202317,200 shares $31.99 thousand -51.6%0.1%0.3 $1.86
2/28/202335,500 shares $77.75 thousand -47.6%0.2%0.7 $2.19
2/15/202367,700 shares $176.70 thousand +35.4%0.4%1.2 $2.61
1/31/202350,000 shares $115.00 thousand -40.7%0.3%0.8 $2.30
1/15/202384,300 shares $182.09 thousand +28.9%0.5%1.3 $2.16
12/30/202265,400 shares $75.21 thousand +127.9%0.4%1.1 $1.15
12/15/202228,700 shares $40.47 thousand +25.3%0.2%0.5 $1.41
You’ve never seen anything like this before (Ad)

For centuries, families like the Rothschilds, Morgans, and Rockefellers have quietly used one overlooked type of finance to build lasting wealth. Legendary investor Joel Greenblatt calls it 'the closest thing to a perpetual motion machine you will ever see.' One investor famously turned 50000 dollars into 900 million using this approach. Porter Stansberry breaks down its origins and mechanics in a new free documentary.tc pixel

Stream the free documentary now to learn the full story
11/30/202222,900 shares $35.95 thousand +2.7%0.1%0.4 $1.57
11/15/202222,300 shares $40.14 thousand -0.5%0.1%0.3 $1.80
10/31/202222,400 shares $45.02 thousand -47.5%0.1%0.3 $2.01
10/15/202242,700 shares $81.34 thousand -17.3%0.3%0.7 $1.91
9/30/202251,600 shares $97.52 thousand +32.3%0.3%0.9 $1.89
9/15/202239,000 shares $95.16 thousand -14.5%0.2%0.7 $2.44
8/31/202245,600 shares $98.04 thousand -9.7%0.3%0.8 $2.15
8/15/202250,500 shares $108.58 thousand -0.4%0.3%0.5 $2.15
7/31/202250,700 shares $81.63 thousand -11.1%0.3%0.5 $1.61
7/15/202257,000 shares $100.32 thousand +325.4%0.4%0.5 $1.76
6/30/202213,400 shares $23.18 thousand -68.2%0.1%0.1 $1.73
6/15/202242,100 shares $73.68 thousand -17.8%0.3%0.4 $1.75
5/31/202251,200 shares $67.07 thousand +85.5%0.3%0.4 $1.31
5/15/202227,600 shares $39.19 thousand +17.0%0.3%0.4 $1.42
4/30/202223,600 shares $39.65 thousand -60.9%0.2%0.4 $1.68
4/15/202260,300 shares $151.35 thousand +1.3%0.6%0.9 $2.51
3/31/202259,500 shares $130.90 thousand -35.0%0.6%0.8 $2.20
3/15/202291,500 shares $167.45 thousand +37.6%0.9%0.9 $1.83
2/28/202266,500 shares $123.03 thousand -26.4%0.6%0.5 $1.85
2/15/202290,300 shares $190.53 thousand -24.0%0.8%0.7 $2.11
1/31/2022118,800 shares $285.12 thousand +52.3%1.3%0.7 $2.40
1/15/202278,000 shares $188.76 thousand -41.7%N/A0 $2.42
12/31/2021133,700 shares $405.11 thousand +188.2%1.4%0.7 $3.03
12/15/202146,400 shares $110.43 thousand -16.3%0.5%0.2 $2.38
11/30/202155,400 shares $156.23 thousand -0.7%0.6%0.4 $2.82
11/15/202155,800 shares $195.86 thousand -21.9%0.6%0.4 $3.51
10/29/202171,400 shares $235.62 thousand +152.3%0.8%0.4 $3.30
10/15/202128,300 shares $96.79 thousand -41.4%0.3%0.2 $3.42
9/30/202148,300 shares $173.40 thousand -42.0%0.5%0.3 $3.59

DMRA Short Interest - Frequently Asked Questions

Short interest is the volume of Damora Therapeutics, Inc. Common Stock shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 4,131,367 shares of DMRA short. 6.72% of Damora Therapeutics, Inc. Common Stock's shares are currently sold short. Learn More on Damora Therapeutics, Inc. Common Stock's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DMRA shares currently have a short interest ratio of 13.3. Learn More on Damora Therapeutics, Inc. Common Stock's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.72% of Damora Therapeutics, Inc. Common Stock's floating shares are currently sold short.

Damora Therapeutics, Inc. Common Stock saw a drop in short interest in the month of August. As of August 31st, there was short interest totaling 4,131,367 shares, a drop of 12.8% from the previous total of 4,739,939 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

6.72% of Damora Therapeutics, Inc. Common Stock's shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Damora Therapeutics, Inc. Common Stock: CG Oncology, Inc. (13.50%), Oruka Therapeutics, Inc. (15.39%), Scholar Rock Holding Corporation (16.48%), Mirum Pharmaceuticals, Inc. (10.37%), Travere Therapeutics, Inc. (13.33%), Kiniksa Pharmaceuticals International, plc (10.11%), Dianthus Therapeutics, Inc. (15.90%), Cogent Biosciences, Inc. (11.57%), Erasca, Inc. (10.41%), Xenon Pharmaceuticals Inc. (6.76%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($62.68 billion), Invesco QQQ ($47.06 billion), iShares Russell 2000 ETF ($23.54 billion), SPDR S&P Biotech ETF ($12.10 billion), Nebius Group N.V. ($9.34 billion), Western Digital Corporation ($8.96 billion), Financial Select Sector SPDR Fund ($8.16 billion), iShares 20+ Year Treasury Bond ETF ($7.98 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.52 billion), and VanEck Semiconductor ETF ($7.39 billion). View all of the most shorted stocks.

Short selling DMRA is an investing strategy that aims to generate trading profit from Damora Therapeutics, Inc. Common Stock as its price is falling. DMRA shares are trading down $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Damora Therapeutics, Inc. Common Stock occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DMRA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DMRA, twice per month. The most recent reporting period available is August, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like DMRA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Short interest data for NASDAQ:DMRA is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 9/10/2026. FINRA publishes updated short interest twice a month.
From Our Partners